Growth investors are justifiably questioning Twilio’s growth and path to profitability as stock-based compensation rises and costs mount. More
Articles
Clover Health Is Risky But Offers a Healthy Upside Ahead
Clover Health's robust fourth quarter and upbeat guidance has improved the risk/reward opportunity of CLOV stock. More
SafeMoon Is Not Safe, And Definitely Not Heading to the Moon
SafeMoon was one of 2021's crazier cryptocurrency stories. However, there's absolutely zero investment rationale for the project in 2022. More
SoFi’s Gone Well Beyond Its Student Loan Days
SOFI stock won't be hurt by the Biden administration's extension of the pause in student loan payments. Here's why that's the case. More
The Stage Is Set for Continued Evgo Stock Growth
EVGO stock's growth momentum should continue as the government and car makers push to expand the national fast charging network. More
